Skip to main content

Our Track Record

Stepler KE, Gillyard TR, Reed CB, Avery TM, Davis JS, Robinson RAS. ABCA7, a Genetic Risk Factor Associated with Alzheimer's Disease Risk in African Americans. Journal of Alzheimer’s Disease2022. JAD vol. 86: 5-19. doi: 10.3233/JAD-215306.

Desaire H, Stepler KE, Robinson RAS. Exposing the Brain Proteomic Signatures of Alzheimer's Disease in Diverse Racial Groups: Leveraging Multiple Data Sets and Machine Learning. Journal of Proteome Research2022 Mar 11. doi: 10.1021/acs.jproteome.1c00966.

Khan MJ, Chung NA, Hansen S, Dumitrescu L, Hohman TJ, Kamboh MI, Lopez OL, Robinson RAS. Targeted Lipidomics To Measure Phospholipids and Sphingomyelins in Plasma: A Pilot Study To Understand the Impact of Race/Ethnicity in Alzheimer's Disease. Analytical Chemistry2022 Mar 2. doi: 10.1021/acs.analchem.1c03821.

Canto AM, Godoi AB, Matos AHB, Geraldis JC, Rogerio F, Alvim MKM, Yasuda CL, Ghizoni E, Tedeschi H, Veiga DFT, Henning B, Souza W, Rocha CS, Vieira AS, Dias EV, Carvalho BS, Gilioli R, Arul AB, Robinson RAS, Cendes F, Lopes-Cendes I. Benchmarking the proteomic profile of animal models of mesial temporal epilepsy. Annals of Clinical and Translational Neurology 2022 Mar 3. doi: 10.1002/acn3.51533.

Pumford A*, Arul A, Ford KI, Robinson RAS. Automation of On-Resin Enrichment of S-Nitrosylated Proteins for Oxidized Cysteine-Selective cPILOT. Vanderbilt Undergraduate Research Journal2021, 11. DOI: 10.15695/vurj.v11i1.5096

Khan MJ, Desaire H, Lopez OL, Kamboh MI, Robinson RAS. Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma. Journal of Alzheimer’s Disease. 2021; 79(3):1327-1344. doi: 10.3233/JAD-201318. Erratum in: Journal of Alzheimer’s Disease2021;80(4):1739.

Khan MJ, Desaire H, Lopez OL, Ilyas Kamboh M, Robinson RAS*. Dataset of Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma. Data in Brief. 2021 Mar 1; vol 35:106923. doi: 10.1016/j.dib.2021.106923.

Stepler KE, Mahoney ER, Kofler J, Hohman TJ, Lopez OL, Robinson RAS*. Inclusion of African American/Black Adults in a Pilot Brain Proteomics Study of Alzheimer's Disease. Neurobiology of Disease2020 Dec; 146:105129. doi: 10.1016/j.nbd.2020.105129.

Robinson RAS, Williams IC, Cameron JL, Ward K, Lingler JH*. Framework for Creative Storytelling Materials to Promote African American/Black Adult Enrollment in Research on Alzheimer’s Disease and Related Disorders. Alzheimer's & Dementia (New York, N. Y.)2020, 6(1): e12076. DOI : 10.1002/trc2.12076.

Khan MJ, Codreanu SG, Goyal S, Wages PA, Gorti SKK, Pearson MJ, Uribe I, Sherrod SD, McLean JA, Porter NA, Robinson RAS. Evaluating a targeted multiple reaction monitoring approach to global untargeted lipidomic analyses of human plasma. Rapid communications in mass spectrometry2020 Nov 30; 34(22): e8911. doi: 10.1002/rcm.8911.

Publications on PubMed
Publications on Google Scholar

  • Stepler, K.E. & Robinson, Renã A.S. The Potential of ‘Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer’s Disease in African Americans. In Reviews on Biomarkers in Psychiatric and Neurodegenerative Disorders, Guest, P. C., Ed. Springer International Publishing: Cham, 2019; Vol. 1118, pp 1-28.

  • Jiang, W., Chung, N. A., May, J. C., McLean, J. A. and Robinson, R. A. (2019). Ion Mobility–Mass Spectrometry. In Encyclopedia of Analytical Chemistry, R. A. Meyers (Ed.). doi:10.1002/9780470027318.a9292.pub2
  • "S-Nitrosylation in Alzheimer’s Disease Using Oxidized Cysteine-Selective cPILOTDyer, Ryan R.; Gu, Liqing; Robinson, Renã A. S. In: Santamaría E., Fernández-Irigoyen J. (eds) "Current Proteomic Approaches Applied to Brain Function." Neuromethods, 2017, vol 127. Humana Press, New York, NY. DOI: 10.1007/978-1-4939-7119-0_14
  • "Proteomic Methods in Neuropsychiatric Research" Robinson, Renã A. S.; Amin, Bushra  in Advances in Experimental Medicine and Biology, ed Paul C. Guest. Springer International Publishing AG: Switzerland, 2017.  DOI 10.1007/978-3-319-52479-5_2.